Table 1.
Groups of immunosuppressive agents and categories of indication
| Immunosuppressive medication | n/N (%) | Indication | n/N (%) |
|---|---|---|---|
| Glucocorticoids | 45/87 (52) | Auto-immune disease | 38/87 (44) |
| Glucocorticoids + small molecule drugs | 13/87 (15) | Rheumatoid arthritis | 12/38 (32) |
| Glucocorticoids + cytostatic drugs | 9/87 (10) | Ulcerative colitis | 7/38 (18) |
| Glucocorticoids + protein drugs | 3/87 (3) | Polymyalgia rheumatica | 5/38 (13) |
| Glucocorticoids + SMD + PD | 1/87 (1) | Auto-immune hepatitis | 3/38 (8) |
| Cytostatic drugs | 9/87 (10) | Systemic lupus erythematosus | 3/38 (8) |
| Cytostatic drugs + protein drugs | 1/87 (1) | Other auto-immune disease | 8/38 (21) |
| Small molecule drugs | 6/87 (7) | Cancer | 21/87 (24) |
| Median dosage prednisone in mga | 20 (7–30)b | Renal transplantation | 6/87 (7) |
| Other | 11/87 (13) | ||
| Unknown | 4/87 (5) |
PD protein drugs, SMD small molecule drugs
aKnown in 46 of 71 patients
bInterquartile range